Laser nail fungus treatment marketing: FDA and FTC rules

Laser treatment for toenail fungus is a common cash-pay service in podiatry offices and some med spas and dermatology practices. The ads write themselves: “kill nail fungus in one painless session,” “no pills,” “FDA approved laser,” “clear nails guaranteed.” Each of those phrases goes past what FDA actually cleared these lasers to do, and the gap is wide enough that a careful page reads very differently from a typical one.

This guide covers what the FDA record says these lasers are cleared for, why “temporary increase of clear nail” is not the same as a cure, how 510(k) clearance may and may not be described, and how FTC rules apply to results claims, reviews, packages and guarantees. For the wider specialty, see our guide to podiatry practice marketing.

This is general information, not legal or medical advice. Sources cited were checked on November 1, 2026: the FDA product classification record for product code PDZ and the 510(k) decisions under it, read through openFDA (device data last updated October 19, 2026); the 510(k) summaries or indications statements for K093547 (decision October 15, 2010), K221363 (July 20, 2022), K241116 (July 22, 2024) and K253960 (March 9, 2026) on FDA’s accessdata site; prescribing information for FDA-approved onychomycosis drugs as listed in openFDA (drug label data last updated October 30, 2026); 21 CFR 807.97, 878.4810, 16 CFR 255.2 and 233.1 in the eCFR version as of October 29, 2026; 21 USC 352 and 15 USC 45, 52 and 55 in the Cornell LII text of the U.S. Code; and the FTC Health Products Compliance Guidance (December 2022). We did not review the medical literature on laser outcomes, ad platform policies, or state rules on who may operate a medical laser.

The short version

The cleared use is narrow. FDA’s product code for these devices, PDZ, is named “Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis.” Every PDZ clearance we read uses that indication.
Clear nail is not a cure. FDA-approved onychomycosis drug labels define complete cure as a clinically clear nail plus negative lab tests for fungus. The laser indication speaks only to clear nail, and only to a temporary increase.
Cleared, not approved. Under 21 CFR 807.97, a 510(k) clearance does not in any way denote official approval, and a representation that creates that impression is misleading.
FTC rules apply. “Kills fungus,” “permanent,” “one session” and success rates are health claims that need competent and reliable scientific evidence, and so do reviews and testimonials that say the same things.

What FDA cleared these lasers to do

FDA’s product classification record for product code PDZ (openFDA, device data last updated October 19, 2026) lists the device name as “Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis,” a Class II device reviewed by the general and plastic surgery panel and listed under 21 CFR 878.4810, the regulation for laser surgical instruments used in general and plastic surgery and in dermatology. The record defines the use as “for the temporary increase of clear nail in patients with onychomycosis,” naming dermatophytes such as Trichophyton rubrum and T. mentagrophytes and yeasts such as Candida albicans as examples.

openFDA returned 19 premarket notification (510(k)) decisions under that code, every one of them substantially equivalent, from October 15, 2010 (K093547) to March 9, 2026 (K253960). Some lasers carry this indication alone. Others are multi-purpose surgical lasers that list it next to soft tissue uses such as matrixectomy and warts.

The 510(k) summaries are worth reading before you write a page, because they show how little the cleared claim says:

K093547 (October 15, 2010). The summary states that a clinical study demonstrated safety and effectiveness for the temporary increase of clear nail at 6 and 12 months following treatment in patients with onychomycosis. The indications statement is marked for prescription use.
K221363 (July 20, 2022). The summary lists the device as Class II prescription use and states that no clinical testing was conducted as part of the submission. Clearance rested on comparison with a predicate device.
K241116 (July 22, 2024). The performance data section is a non-clinical test summary: electrical safety, electromagnetic compatibility and laser safety standards.
K253960 (March 9, 2026). The indication is again the temporary increase of clear nails in patients with onychomycosis.

So the most a clearance tells a patient is that a laser of that type was shown, at some point, to temporarily increase the amount of clear nail. It does not say the fungus is gone, that the result lasts, that one session is enough, or that the laser works as well as medication. If you do not know which 510(k) covers the laser in your office, ask the manufacturer for the K number and read the indications for use in FDA’s 510(k) database before you write anything about it.

Why “clear nail” is not “cured”

FDA-approved prescription drugs for onychomycosis are judged on a stricter endpoint. The prescribing information for one approved topical antifungal for toenail onychomycosis (label effective September 15, 2025, as listed in openFDA) defines complete cure as 0% clinical involvement of the target toenail plus a negative potassium hydroxide (KOH) preparation and a negative fungal culture. In other words, a cure in the drug labels means the nail looks normal and the lab finds no fungus.

The laser indication covers the first half of that, partially and temporarily. A nail can look clearer while the infection is still present. That is the core reason “cure,” “eliminates,” “kills 100% of fungus” and “gone for good” do not match the cleared use.

The labels also show that diagnosis comes first. The prescribing information for the approved oral antifungal for onychomycosis (for example, a version effective September 1, 2024, in openFDA) says nail specimens for laboratory testing, such as a KOH preparation, fungal culture or nail biopsy, should be obtained to confirm the diagnosis before treatment. A thick, discolored nail is not always fungal, so a page that invites anyone with “ugly toenails” to book a laser session skips a step the drug labels treat as basic.

“FDA cleared” and “FDA approved”

21 CFR 807.97 says that a 510(k) submission and FDA’s finding of substantial equivalence do not in any way denote official approval of the device, and that any representation that creates an impression of official approval because of the 510(k) process is misleading and constitutes misbranding. Under 21 USC 352(a), a device is misbranded if its labeling is false or misleading in any particular. Those rules are written for the device and its labeling, but the same words on a clinic’s page can mislead patients, and under the FTC Act a misleading ad is a problem for whoever runs it.

Wording that fits the record:

“Our laser is FDA cleared for the temporary increase of clear nail in patients with onychomycosis.”
“FDA cleared” only for the specific device you use, and only for the indication in its clearance.

Wording that does not:

“FDA approved laser” or “FDA approved nail fungus treatment.”
“FDA cleared to cure (or kill, or eliminate) nail fungus.”
“FDA cleared” placed next to claims the clearance does not cover, so the reader assumes FDA reviewed them.

Our guide to medical device marketing claims covers clearance, approval and off-label wording across specialties.

What the FTC requires

Section 5 of the FTC Act declares unfair or deceptive acts or practices unlawful (15 USC 45(a)), and section 12 makes it unlawful to disseminate a false advertisement to induce the purchase of drugs, devices or services (15 USC 52). Under 15 USC 55(a)(1), whether an ad is misleading includes what it fails to reveal about the consequences of using the product as advertised.

The FTC Health Products Compliance Guidance says health claims need competent and reliable scientific evidence, and that the FTC reads an ad for its net impression, including claims that are implied rather than stated. Typical nail fungus laser claims that need that level of support:

Results. “Kills the fungus,” “cures,” “permanent results,” “clear nails in one treatment.” The clearance supports a temporary increase in clear nail, nothing more.
Success rates. “90% success rate” or “most patients see results” needs evidence for your device, your protocol and the outcome you are describing, and clear-nail percentages should not be presented as cure rates.
Comparisons. “Works better than pills” or “as effective as medication without the side effects” is a comparative efficacy and safety claim. The clearances we read do not compare lasers with drugs.
Comfort and safety. “Painless,” “no side effects” and “no downtime” are factual claims you need to be able to support for your device and settings.
Timing. Nails grow out slowly, and the K093547 summary measured results at 6 and 12 months. A page that shows a dramatic change after one visit sets an expectation the record does not support.

Leaving out facts can mislead too. If your protocol usually needs several sessions, if results take months to judge, or if you advise patients that the infection may come back, say so near the price and the booking button (15 USC 55(a)(1)).

Reviews, testimonials and before-and-after photos

Under 16 CFR 255.2(a), an advertiser must have substantiation for what a consumer endorsement conveys, just as if it made the claim itself. A review that says “one laser session and my fungus was gone” carries a cure claim the practice would need to support if it features that review in an ad or on its service page. Under 16 CFR 255.2(b), an endorsement about a central attribute is likely to be read as representing typical results, unless the ad clearly and conspicuously discloses the generally expected results.

Before-and-after photos raise the same issue. Show the time between photos, the number of sessions, and whether the patient also used medication, and do not use a photo of a nail that cleared after combined treatment to sell the laser alone. Get written patient authorization before using any patient photo. See our guide to patient testimonials and before-and-after photos.

Packages, prices and guarantees

Laser nail treatment is usually self-pay, which brings price and offer rules into play:

Say what the price covers. Number of sessions, how many nails, whether the exam, lab testing, nail debridement and follow-up visits are included, and whether topical products cost extra.
Former prices must be real. A “was $1,200, now $499” comparison needs a former price the practice actually offered in good faith for a reasonably substantial period (16 CFR 233.1(a)).
Guarantees need conditions in plain view. “Clear nails or your money back” is both a results claim and an offer. If there are conditions, such as completing every session or using a topical between visits, put them next to the guarantee. See money-back guarantees in healthcare ads.
Do not imply insurance coverage unless you have checked it for the patient’s plan, and say clearly when a service is self-pay.

Our guides to advertising cash prices and advertising patient financing cover the rest.

What you can say

That the practice offers laser treatment for onychomycosis, using a laser FDA cleared for the temporary increase of clear nail in patients with onychomycosis.
How you confirm the diagnosis before treatment, and who examines the patient.
What a session involves, how many sessions your protocol uses, and that results are judged as the nail grows out over months.
That a clear-looking nail is not the same as a lab-confirmed cure, and that the infection can return, if your clinicians advise patients that way.
What other options exist, such as prescription medication, and that the clinician will discuss them.
Price, inclusions, refund terms and any guarantee conditions.

Leave out: “cure,” “kills” or “eliminates” fungus, “permanent,” “one and done,” “FDA approved,” success rates you cannot support for your own device and protocol, “better than pills,” “painless” or “no side effects” without evidence, and reviews that make any of those claims.

An example (made up)

This illustration is invented. A med spa runs this ad: “FDA approved laser kills toenail fungus in ONE painless 30-minute session. 95% cure rate. No pills, no side effects. Was $900, now $299. Clear nails guaranteed!”

Fixes: “FDA approved” becomes “FDA cleared,” and only with the cleared indication. “Kills toenail fungus” and “95% cure rate” come off, because the cleared use is a temporary increase of clear nail and a cure requires negative lab tests as well. “ONE session” comes off unless that is the actual protocol and the med spa has evidence it works. “Painless” and “no side effects” stay only with support for this device and these settings. The “was $900” price stays only if patients actually paid it for a reasonable period. “Clear nails guaranteed” either comes off or gets its conditions next to it. The page should add how the diagnosis is confirmed, how many sessions to expect and when results can be judged.

Checklist

Know the K number for your laser and read its indications for use (FDA 510(k) database).
Describe it as FDA cleared for the temporary increase of clear nail in patients with onychomycosis, never as FDA approved (21 CFR 807.97).
No cure, kill, eliminate or permanent claims, and no clear-nail rates presented as cure rates (15 USC 45, 52; FTC guidance).
Diagnosis step described, including lab testing if your clinicians use it.
Number of sessions, time to judge results and recurrence advice stated where the service is sold (15 USC 55(a)(1)).
Comparisons with medication, comfort claims and success rates backed by competent and reliable scientific evidence.
Reviews and photos do not say what the practice could not say, and typical results are disclosed (16 CFR 255.2).
Prices, inclusions, former prices and guarantee conditions are real and clear (16 CFR 233.1).
State rules on who may operate the laser checked with counsel, especially for med spas.
Google ads, social posts, review responses and phone scripts match the website.

How we help

We build service pages for podiatry, dermatology and med spa practices with claims checked against the sources above: website design, healthcare SEO for treatment searches like “laser toenail fungus near me,” and lead generation campaigns that describe treatments without approval, cure or guarantee overclaims. We do not decide whether a treatment works, we do not give legal opinions, and we are not a law firm. Related guides: laser hair removal clinic marketing, laser tattoo removal clinic marketing and dermatology practice marketing.

Can we say our nail fungus laser is FDA approved?

No. These lasers reach the market through 510(k) clearance under product code PDZ. 21 CFR 807.97 says a 510(k) clearance does not in any way denote official approval and that implying approval is misleading. Say FDA cleared, with the cleared indication.

What exactly is the FDA cleared use?

The temporary increase of clear nail in patients with onychomycosis. That is the name of product code PDZ and the indication in every PDZ clearance we read, from K093547 (October 15, 2010) to K253960 (March 9, 2026).

Can we say the laser cures nail fungus?

We advise against it. FDA-approved onychomycosis drug labels define complete cure as a clinically clear nail plus negative KOH and culture tests. The laser clearance covers only a temporary increase in clear nail, and the FTC requires competent and reliable scientific evidence for health claims.

Can we post a review that says the fungus was gone after one visit?

Not in your ads unless you could support that claim yourself. Under 16 CFR 255.2, the practice needs substantiation for what a featured endorsement conveys, and results described as central are likely to be read as typical.

Can we compare laser treatment with prescription pills?

Only with evidence for the comparison. The 510(k) clearances we read do not compare lasers with drugs, and a claim like “works better than pills with no side effects” is both an efficacy and a safety claim.

Sources

More in Cash-pay, aesthetic and wellness care

Laser nail fungus treatment marketing: cleared wording vs cure claims